Improving Donor Livers by Inhibiting TNF-α Production
Overview
Affiliations
Hepatic ischemia/reperfusion (I/R) injury has a significant influence on the outcome of liver transplants. Inhibiting certain enzymatic reactions that occur during I/R injury may have a protective effect on the liver during transplantation. After reviewing the biochemical pathways involved in hepatic I/R injury, we describe a pharmacologic line of defense against this injury by means of the enzyme tissue inhibitor of metalloproteinase 3 (TIMP-3). Current results suggest that TIMP-3 will play a clinically relevant role in improving outcomes of liver transplants by reducing I/R injury to the donor liver.
Tao Y, Wen Z, Song Y, Wang H Exp Ther Med. 2016; 11(1):263-268.
PMID: 26889252 PMC: 4726947. DOI: 10.3892/etm.2015.2902.
Tumor Necrosis Factor-α: Life and Death of Hepatocytes During Liver Ischemia/Reperfusion Injury.
Shuh M, Bohorquez H, Loss Jr G, Cohen A Ochsner J. 2013; 13(1):119-30.
PMID: 23531747 PMC: 3603175.
Zhang J, Hu W, Xing W, You T, Xu J, Qin X Am J Pathol. 2011; 179(6):2876-84.
PMID: 22019898 PMC: 3260856. DOI: 10.1016/j.ajpath.2011.08.040.